FT
HALO icon

Fiduciary Trust’s Halozyme HALO Stock Holding History

Fiduciary Trust’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$547K Sell
6,983
-15
-0.2% -$1.02K 0.01% 577
2026
Q1 		$452K Buy
6,998
+1,276
+22% +$90K 0.01% 597
2025
Q4 		$385K Sell
5,722
-10
-0.2% -$673 ﹤0.01% 641
2025
Q3 		$420K Sell
5,732
-1,020
-15% -$67.8K ﹤0.01% 601
2025
Q2 		$351K Hold
6,752
– – ﹤0.01% 629
2025
Q1 		$431K Buy
+6,752
New +$392K 0.01% 554

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Fiduciary Trust's HALO Position: Q2 2026 in Review

Fiduciary Trust reduced its Halozyme (HALO) stake by 0.21% in Q2 2026, selling an estimated $1.02K and leaving 6,983 shares worth $547K. The position accounts for 0.01% of the portfolio, ranked #577.

Fiduciary Trust first reported a position in HALO in Q1 2025 and has held it in 6 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Fiduciary Trust held 6,983 shares of Halozyme worth $547K as of Q2 2026.
  • Fiduciary Trust sold 15 Halozyme shares in Q2 2026, an estimated $1.02K.
  • Halozyme made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #577 holding.
  • Fiduciary Trust first reported a position in Halozyme in Q1 2025 and has held it in 6 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.